Clinical trial
Effects of Nitric Oxide and Nitroglycerin in Patients With Sickle Cell Anemia
NCT00001716 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00001716 |
|---|---|
| Title | Effects of Nitric Oxide and Nitroglycerin in Patients With Sickle Cell Anemia |
| Official title | Physiologic Effects of Inhaled Nitric Oxide, Nitroglycerin, and Placebo in Study Subjects With Sickle Cell Anemia |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chest Pain, Sickle Cell Anemia |
| Intervention type | Drug |
| Interventions | Nitric Oxide, Nitroglycerin |
| Enrollment | 58 |
| Start date | Jul 1, 1998 |
| Completion | Jul 1, 2003 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: